Small-cap stocks tend to fly under the radar. Often in startup stages, these companies can lack anal

[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced new interim data fro

Inventiva NASDAQ: IVA said it expects to report top-line results in the fourth quarter of 2026 from

Inventiva S.A. Sponsored ADR (NASDAQ: IVA - Get Free Report)'s share price gapped down before the ma

Truist Securities analyst Srikripa Devarakonda maintains Inventiva (NASDAQ:IVA) with a Buy and ra

Inventiva S.A. Sponsored ADR (NASDAQ: IVA - Get Free Report) shares gapped up prior to trading on We

Gainers DataMEDS AI (NASDAQ:MEDS) stock moved upwards by 39.4% to $4.42 during Thursday's pre-m

U.S. stock futures were mixed as Progress Software fell after results; Corteva, NFT, Vivakor and oth

Inventiva S.A. Sponsored ADR (NASDAQ: IVA - Get Free Report) has earned a consensus rating of "Buy"

Vicor shares surged 12% after raising Q3 growth guidance above 30%; Roze AI led gainers, while Corte

U.S. stocks rose as Nasdaq gained 100+ points; HPE jumped 5.1% on stronger networking guidance and a

Inventiva S.A. Sponsored ADR (NASDAQ: IVA - Get Free Report) shares rose 5.5% on Monday. The stock t

Canaccord Genuity analyst Edward Nash maintains Inventiva (NASDAQ:IVA) with a Buy and raises the

U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Tuesday.

U.S. futures mixed as Vail Resorts fell after a Q4 loss miss despite beating sales estimates; severa

Inventiva S.A. (IVA) Q2 2026 Earnings Call Transcript

Inventiva NASDAQ: IVA said it remains on track to report top-line results from its Phase III NATiV3

Inventiva (NASDAQ: IVA) said it remains on track to report top-line results from its Phase III NATiV

On Monday, Inventiva (NASDAQ:IVA) discussed quarterly financial results during its earnings call. Th

Companies Reporting Before The Bell • Kandi Technologies Gr (NASDAQ:KNDI) is likely to report earnin

Inventiva (NASDAQ:IVA) reported quarterly losses of $(0.29) per share which missed the analyst conse

Daix (France), New York (New York, United States), September 28, 2026 – Inventiva (Euronext Paris an

Companies Reporting Before The Bell • Tamboran Resources (NYSE:TBN) is estimated to report quarterly

U.S. futures rose, but Novo Nordisk fell 4.8% after Cagrisema trial results; Aligos, Telix and other

Inventiva S.A. (IVA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Guggenheim analyst Seamus Fernandez maintains Inventiva (NASDAQ:IVA) with a Buy and raises the pr

Daix (France), New York (New York, United States), September 8, 2026 – Inventiva (Euronext Paris and

Paris, 08 September 2026, 7:00am EBITDA at €434m, +18% yoy reflecting sustained demand, disciplined

Last patient completed final 72-week visit in NATiV3, with 1,009 patients enrolled in the main cohor

Daix (France), New York (New York, United States), September 2nd, 2026 – Inventiva (Euronext Paris a

Gainers Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday

Daix (France), New York City (New York, United States), August 31, 2026 –  Inventiva (Euronext Paris

U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Monday. S

Inventiva is positioned as a high-risk, clinical catalyst play targeting MASH with its oral pan-PPAR

Inventiva (Euronext Paris and NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical

Daix (France), New York City (New York, United States), July 30, 2026 – Update to Press Release Date

Daix (France), New York City (New York, United States), July 29, 2026 – Inventiva (Euronext Paris an

ADAR1 Capital Management LLC decreased its holdings in shares of Inventiva S.A. Sponsored ADR (NASDA

US stock futures lower with Dow down 500 points. Kura Sushi shares drop after reporting worse-than-e

Europe's largest independent growth debt fund manager has made an investment through its funds,

US stock futures lower, Nasdaq down 1%. Super Micro shares down 8.6% after announcing $7B offering t

Secured a new debt financing with funds and accounts managed by BlackRock and Claret Capital Partner

 Inventiva (NASDAQ:IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmace

U.S. stock futures rise on Tuesday with Dow futures up 400 points. Phreesia shares fall 26.5% in pre

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its s

Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst conse

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of pu

Newsmax Inc (NMAX) shares rose on better-than-expected Q4 results & FY26 sales guidance. Pre-mar

Wall Street analysts changed outlook on top names. Clear Street initiated coverage on RKLB with Buy